On this page
Adapalene Paraben Free
Adapalene · Gel
Over-the-counter ANDA
Informational index, not medical advice. Content is reproduced from
public FDA and NLM data. Always confirm against the manufacturer's current
prescribing information. Report adverse events to FDA MedWatch.
Overview
Brand name
Adapalene Paraben Free
Generic name
Adapalene
Dosage form
Gel
Route
Topical
Marketing category
ANDA · ANDA
Labeler
CVS PHARMACY, INC
Product type
Human Otc Drug
DEA schedule
Not scheduled
Active ingredients
1
NDC product codes
4
Packages
5
Data completeness
54%
of corroborating sources present
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Adapalene | 1 mg/g | 829539 | View |
Forms, strengths and routes
Source: NDC DirectoryDosage form
Gel
Route of administration
Topical
Presentations
9
Pharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Retinoid [EPC] | EPC | All 35 members |
| Retinoids [CS] | CS | All 35 members |
Regulatory status
Source: Drugs@FDANDC DirectoryApplication number
090962
Application type
ANDA · Abbreviated New Drug Application
Approval date
June 2, 2010
Sponsor
P AND L
Products on application
1
Submissions recorded
3
| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 090962-001 | ADAPALENE | GEL | ADAPALENE | Over-the-counter | — |
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 8 | Manufacturing (CMC) | Approved | March 10, 2026 | Unknown |
| Supplement | 5 | Manufacturing (CMC) | Approved | July 8, 2019 | Unknown |
| Original application | 1 | Approved | June 2, 2010 | — |
Review documents
- 0 · Original application · June 8, 2010
Adverse event reports
Source: openFDA FAERS181,513
FAERS reports mentioning this drug
A report count is not a risk measure. FAERS accepts voluntary and
mandatory reports without establishing causation, and reporting is influenced by how
widely a drug is used, how long it has been marketed, and media attention. FDA states
that reports “do not prove that the drug caused the event”. Compare rates, not totals.
Attributed to this product's most-reported active ingredient: ADAPALENE. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 51316-219-05 | 51316-219 | CVS PHARMACY, INC | 1 TUBE in 1 CARTON (51316-219-05) / 15 g in 1 TUBE | September 15, 2026 |
| 51316-219-16 | 51316-219 | CVS PHARMACY, INC | 1 TUBE in 1 CARTON (51316-219-16) / 45 g in 1 TUBE | September 15, 2026 |
| 79481-2210-5 | 79481-2210 | Meijer Distribution Inc. | 1 TUBE in 1 CARTON (79481-2210-5) / 15 g in 1 TUBE | September 15, 2026 |
| 30142-542-05 | 30142-542 | The Kroger Co. | 1 TUBE in 1 CARTON (30142-542-05) / 15 g in 1 TUBE | September 15, 2026 |
| 76162-221-05 | 76162-221 | Topco Associates | 1 TUBE in 1 CARTON (76162-221-05) / 15 g in 1 TUBE | September 15, 2026 |
| 51316-219 | 51316-219 | CVS PHARMACY, INC | — | September 15, 2026 |
| 79481-2210 | 79481-2210 | Meijer Distribution Inc. | — | September 15, 2026 |
| 30142-542 | 30142-542 | The Kroger Co. | — | September 15, 2026 |
| 76162-221 | 76162-221 | Topco Associates | — | September 15, 2026 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| FAERS | FDA | Adverse event report counts |
Generated September 25, 2026 · 9 sections on this page.